EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and biochemical assessments of circulating High Mobility Group Box Protein1 in children with epilepsy: relation to cognitive function and drug responsiveness

Hala M Sakhr iD, Mohammed H Hassan, Asmaa E Salah, Ali Helmi Bakri

Neurological Sciences · 2025

DOI: 10.1007/s10072-024-07795-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Hala M Sakhr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt. hala.sakhr@med.svu.edu.eg. Hauptthemen laut MEDLINE: HMGB1 Protein, Drug Resistant Epilepsy, Epilepsy, Cognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South Valley University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood epilepsy is a major health concern posing a significant burden and having disastrous consequences for cognitive function. High Mobility Group Box1 (HMGB1) is an activator of neuroinflammation, and it is possibly involved in the initiation and progression of epilepsy. We aimed to investigate circulating HMGB1 in children with epilepsy and its connection to cognitive function and drug responsiveness.

Methods

Case-control research included 100 epileptic youngsters and 100 healthy matched controls. Serum HMGB1 was measured using a commercially available ELISA assay. Cognitive functions were evaluated by the Stanford-Binet test 5th edition.

Results

Drug-resistant epilepsy (DRE) was found in 37% of the investigated patients. Epileptic children have lower cognitive function parameter levels versus the control group and lower cognitive function in the DRE group compared to the drug-responsive group (P-value < 0.0001). HMGB1 levels were significantly higher in the patients’ group (6.279 µg/L) compared to the control group (2.093 µg/L) and in the drug-resistant group (14.26 µg/L) versus the drug-responsive group (4.88 µg/L). A significant negative correlation was detected between HMGB1 with Full-scale IQ ( r = − 0.547, P = 0.000), Visual-spatial reasoning ( r = − 0.501, P = 0.000), fluid reasoning ( r = − 0.510, P = 0.000), and working memory ( r = − 0.555, P = 0.000). Serum HMGB1 cut-off levels > 6.85 µg/L differentiate drug-responsive from resistant patients.

Conclusion

Elevated HMGB1 levels, especially in patients with drug-resistant epilepsy, correlate negatively with cognitive performance, emphasizing its importance as a potential marker for early prediction of drug resistance and impairment of cognitive function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinDrug Resistant EpilepsyEpilepsyCognitionCognitive DysfunctionHumansMaleFemaleChildCase-Control StudiesAdolescentAnticonvulsantsBiomarkersNeuropsychological TestsChild, Preschool

Stichwörter der Autor:innen

Cognitive functionDrug-resistant epilepsyHigh Mobility Group Box Protein1

Substanzen

HMGB1 ProteinHMGB1 protein, humanAnticonvulsantsBiomarkers

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt. hala.sakhr@med.svu.edu.eg.
  • Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt. mohammedhosnyhassaan@med.svu.edu.eg.
  • Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt.

ORCID-Profile: Hala M Sakhr

Förderung

  • South Valley University

Zitieren

APA

Sakhr, H. M., Hassan, M. H., Salah, A. E., & Bakri, A. H. (2025). Clinical and biochemical assessments of circulating High Mobility Group Box Protein1 in children with epilepsy: relation to cognitive function and drug responsiveness. Neurological Sciences. https://doi.org/10.1007/s10072-024-07795-z

Vancouver

Sakhr HM, Hassan MH, Salah AE, Bakri AH. Clinical and biochemical assessments of circulating High Mobility Group Box Protein1 in children with epilepsy: relation to cognitive function and drug responsiveness. Neurological Sciences. 2025. doi:10.1007/s10072-024-07795-z

BibTeX
@article{Sakhr2025,
  author = {Sakhr, Hala M and Hassan, Mohammed H and Salah, Asmaa E and Bakri, Ali Helmi},
  title = {Clinical and biochemical assessments of circulating High Mobility Group Box Protein1 in children with epilepsy: relation to cognitive function and drug responsiveness},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-024-07795-z}
}
Kostenlos starten →